| P50 | author | Robert A. Hegele | Q58046422 |
| | Murray W Huff | Q87799101 |
| P2093 | author name string | Cynthia G Sawyez | |
| | Jane Y Edwards | |
| | Caroline O'Neil | |
| | J Geoffrey Pickering | |
| | Michael M Beyea | |
| | Samantha Reaume | |
| P2860 | cites work | Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c | Q24300790 |
| | Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol | Q24337975 |
| | LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor | Q24656186 |
| | Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia | Q24657127 |
| | Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes | Q24683425 |
| | Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig | Q24683936 |
| | Molecular biology of PCSK9: its role in LDL metabolism | Q27488922 |
| | Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors | Q28215527 |
| | Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear | Q28255975 |
| | Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 |
| | SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 |
| | Protein sensors for membrane sterols | Q29617313 |
| | Role of smooth muscle cells in the initiation and early progression of atherosclerosis | Q30438867 |
| | Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization | Q33895700 |
| | Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions | Q34143741 |
| | Identification of macrophage liver X receptors as inhibitors of atherosclerosis | Q34154665 |
| | Class A scavenger receptors, macrophages, and atherosclerosis | Q34372269 |
| | Liver X Receptor Signaling Pathways in Cardiovascular Disease | Q35104848 |
| | The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols | Q38296407 |
| | ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. | Q39837617 |
| | Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells | Q39881932 |
| | Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2. | Q40070884 |
| | Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis | Q40142846 |
| | Identification of human low-density lipoprotein receptor as a novel target gene regulated by liver X receptor alpha. | Q40241827 |
| | Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor | Q40528839 |
| | Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation | Q40631077 |
| | Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene | Q40864894 |
| | Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation | Q41084454 |
| | Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias. | Q41692355 |
| | Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery | Q43738115 |
| | Modified low density lipoprotein isolated from atherosclerotic lesions does not cause lipid accumulation in aortic smooth muscle cells | Q44431948 |
| | Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries | Q44940978 |
| | Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells | Q45153424 |
| | LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. | Q46344510 |
| | Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts | Q46845480 |
| | Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo | Q46859453 |
| | Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins | Q47638028 |
| | Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. | Q52831306 |
| P433 | issue | 3 | |
| P921 | main subject | 24(S), 25-epoxycholesterol | Q27071872 |
| P304 | page(s) | e000810 | |
| P577 | publication date | 2012-06-22 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux | |
| P478 | volume | 1 | |